Flutamide

CAS 13311-84-7 4 current records 9 historicalSmall Molecule

Who holds supplier records for Flutamide? 4 organisations hold a current record for Flutamide: an active US FDA Type II Drug Master File or a CEP. A further 9 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Italy (1), Finland (1), India (1) and Spain (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Flutamide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/flutamide

Reading the evidence

  • 4 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (4)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Flutamide. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Flutamide sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (4)

Certificates of Suitability on the EDQM register for Flutamide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 7 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
CURIA ITALY S.R.L. OriggioIT
CEP 2000-049 - Rev 08
Flutamide, Unmilled; milled
May 2026Inspected Apr 2025
Italy
FERMION OY EspooFI
CEP 2002-134 - Rev 05
Flutamide
Feb 2025Inspected Feb 2026
Finland
CORAL DRUGS PRIVATE LIMITED New DelhiIN
CEP 2001-416 - Rev 04
Flutamide
Oct 2024—
DERIVADOS QUIMICOS S.A.U. AlcantarillaES
CEP 2002-159 - Rev 06
Flutamide
Apr 2024Inspected Jun 2025
Spain

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (9)

Organisations whose Type II DMFs for Flutamide are no longer active. These show a past filing, not current supply.

Show all 9 historical records

Overview

Flutamide is a nonsteroidal antiandrogen used primarily to treat prostate cancer. It works by binding to androgen receptors, preventing the action of endogenous androgens in the prostate, which can inhibit tumor growth.

Chemical identity

IUPAC name
2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
Canonical SMILES
CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F
InChIKey
MKXKFYHWDHIYRV-UHFFFAOYSA-N
Synonyms
Eulexin API, eulexin, nsc-215876, sch 13521, sch-13521

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Androgen Receptor Inhibitor
Mechanism of action
Androgen Receptor Antagonists

Therapeutic areas

OncologyUrology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Flutamide?

4 organisations hold an active US FDA Type II Drug Master File or a CEP for Flutamide: CURIA ITALY SRL (Italy), FERMION OY (Finland), CORAL DRUGS PVT LTD (India) and DERIVADOS QUIMICOS SAU (Spain). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Flutamide Drug Master Files are active?

CURIA ITALY SRL (DMF 12807) and FERMION OY (DMF 11522). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Flutamide records mean?

9 organisations have only inactive Type II DMFs for Flutamide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Flutamide have a European Certificate of Suitability?

Yes. 4 organisations hold a valid CEP for Flutamide on the EDQM register, including CURIA ITALY S.R.L. Origgio (IT), FERMION OY Espoo (FI), CORAL DRUGS PRIVATE LIMITED New Delhi (IN) and DERIVADOS QUIMICOS S.A.U. Alcantarilla (ES). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Flutamide supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Flutamide?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.